Oxytocin (OT) release by axonal terminals onto the central nucleus of the amygdala exerts anxiolysis. To investigate which subpopulation of OT neurons contributes to this effect, we developed a novel method: virus-delivered genetic activity-induced tagging of cell ensembles (vGATE). With the vGATE method, we identified and permanently tagged a small subpopulation of OT cells, which, by optogenetic stimulation, strongly attenuated contextual fear-induced freezing, and pharmacogenetic silencing of tagged OT neurons impaired context-specific fear extinction, demonstrating that the tagged OT neurons are sufficient and necessary, respectively, to control contextual fear. Intriguingly, OT cell terminals of fear-experienced rats displayed enhanced glutamate release in the amygdala. Furthermore, rats exposed to another round of fear conditioning displayed 5-fold more activated magnocellular OT neurons in a novel environment than a familiar one, possibly for a generalized fear response. Thus, our results provide first evidence that hypothalamic OT neurons represent a fear memory engram.
INTRODUCTION
Emotional memory representations (also called memory engrams), such as for fear, are pivotal for animal survival. Fearassociated behaviors have evolved over millions of years in living systems, from lower to higher animals, so that they can sense, evaluate, respond, and adapt to adequately deal with dangerous situations (Mobbs et al., 2015) . Fear-related disorders, such as specific phobias and post-traumatic stress disorder (PTSD), are among the most prevalent human psychiatric conditions and pose debilitating health burdens to affected individuals and immense costs to society (Kessler and Bromet, 2013) . Understanding the neural basis of fear learning, expression, and extinction is of paramount importance for PTSD treatment; for example, by targeted circuit-specific therapeutics.
The hypothalamus is an evolutionary old and deeply located brain structure that relays fear-related emotional behavior in mammals. Fear memory engrams are thought to be distributed between the different brain regions in the nervous system; for example, the amygdala, hippocampus, and medial prefrontal cortex (mPFC) (Kitamura et al., 2017) . Notably, the hypothalamus is reciprocally connected to different brain regions, including the amygdala (Knobloch et al., 2012) and the mPFC (Heidbreder and Groenewegen, 2003) , which, in turn, interact with various other brain regions when organizing fear memories (Tovote et al., 2015) . These findings support the view that brain networks, composed of distributed cell assemblies, generate behavior, including the formation of memory representations or engrams. We thus hypothesized that the hypothalamus, being the oldest brain structure, which evolved over time alongside the newer higher brain structures, might be equipped with mechanisms to encode engram-like features and capable of plasticity.
The central nucleus (CeA), a subregion of the amygdala, participates in the acquisition, consolidation, storage, expression, and extinction of fear memories (Ciocchi et al., 2010; Herry et al., 2010; Letzkus et al., 2011) and the subsequent physiological response: freezing behavior (Viviani et al., 2011) . Hypothalamic oxytocin (OT) neurons precisely project to the lateral part of the CeA (CeL), where axonal OT release activates CeL neurons (Knobloch et al., 2012) , which, in turn, inhibit GABAergic neurons in the medial part of the CeA (CeM), attenuating the fear-related freezing response in rodents. However, the precise role of OT neurons and their projections to the CeA during fear learning is still not well understood. It is unknown which fraction of OT neurons contributes to the anxiolytic effect, how OT neurons are recruited during different fear episodes, and whether the hypothalamus-amygdala circuit is subject to fear-dependent plasticity and contextual specificity.
To tackle these questions, we developed a novel genetic method, virus-delivered genetic activity-induced tagging of cell ensembles (vGATE), to tag fear-experience-activated OT neurons in rats during contextual fear conditioning (FC) (Ehrlich et al., 2009; LeDoux, 2007) . Here we provide first evidence that establishes the role of OT neuronal ensembles in fear expression and extinction. We discovered that optogenetic activation of a small subset of fear exposure-activated OT neurons drastically reversed freezing behavior (''unfreezing'') and their silencing impaired context-specific fear extinction. Importantly, fear exposure-tagged OT neurons display an enormous capacity for experience-dependent plasticity by enhancing glutamatergic over OT-ergic transmission in the hypothalamic-amygdalar circuitry. These results clearly demonstrate that fear exposure-tagged OT neurons are both sufficient and necessary for attenuation of fear expression. Altogether, these results satisfy the key criteria of the synaptic plasticity memory hypothesis (Martin et al., 2000) in identifying and validating a fear memory engram in hypothalamic OT circuits. Thus, we conclude that memory engrams are not only restricted to higher brain regions, such as the hippocampus and cortex, but also present in a lower brain region, such as the hypothalamus. This study is a shift in paradigm, revealing the anatomical and functional connectivity organization of fear memory engrams as network-wide distributed cell assemblies that include both higher and lower brain regions.
RESULTS

Activity-Dependent Tagging of OT Neurons
To specifically label activated OT neurons, we developed and describe here a genetic method called vGATE ( Figure 1A ). In the vGATE system, a c-fos promoter (P fos ) fragment (Schilling et al., 1991) drives the expression of the reverse tetracyclinesensitive (tet) transactivator (rtTA) (Dogbevia et al., 2015 (Dogbevia et al., , 2016 . In activated neurons, stimulation of the c-fos promoter rapidly induces rtTA expression. To obtain sustained rtTA expression for permanent tagging of c-fos activated neurons, we designed an autoregulatory expression loop by introducing rtTA-binding DNA sequences (tet operator sequences [(tetO) 7 ]) upstream of P fos to drive rtTA expression (the full genetic module is (tetO) 7 -P fos -rtTA). In the presence of doxycycline (Dox), transient P fos activity drives rtTA expression, which, upon binding to (tetO) 7 , takes over the transient c-fos promoter activity by establishing a Dox-controlled rtTA-dependent and self-sustaining autoregulatory loop ( Figure 1A ) for persistent rtTA expression. A second virus (virus 2) is equipped with a bidirectional tet promoter (P tet bi) that drives the expression of genes encoding for the Cre recombinase and fluorescent proteins ( Figure 1A ). Finally, a third virus (virus 3) is equipped with a cell-type-specific promoter (OT in our case) that drives Cre-dependent expression of any gene(s) ( Figure 1A ).
vGATE-Assisted, Dox-Dependent rtTA Expression
In Vivo As a proof of principle, we first validated the vGATE method in vitro (Figures S1A-S1D) and, subsequently, in vivo. For in vivo validation, we injected the vGATE construct rAAV-(tetO) 7 -P fosrtTA into the supraoptic nucleus (SON) of the hypothalamus. Three weeks later, rats were treated under four different Figure 1 . Operating Principle of the vGATE System and Activity-Dependent Tagging of OT Neurons (A) Scheme of the vGATE system: virus 1 (rAAV-(tetO) 7 -P fos -rtTA), virus 2 (rAAV-P tet bi-Cre/YC3.60), and virus 3 (rAAV-P OT -FLEX-hChR2-mCherry). (B) Rats were injected with vGATE viral cocktail (3 viruses) into the hypothalamic SON and treated with Dox in combination with osmotic stimulation (salt loading). (C) Dox-dependent rtTA expression is only detected in the stimulus + Dox group. To verify correct viral targeting of the SON, the rAAV-(tetO) 7 -P fos -rtTA virus was mixed 1:1 with an rAAV expressing Venus under control of the oxytocin promoter (rAAV-P OT -Venus; Knobloch et al., 2012) . (D) In euhydrated rats (basal, top panel), Dox injection induces rtTA-dependent YC3.60 (via virus 2, green) and red) signals in a few scattered neurons. In contrast, both signals were detected in the majority of SON OT neurons (blue) after Dox injection to osmotically challenged, salt-loaded rats (stimulated, bottom panel). (E) Expression of the endogenous c-fos signal (visualized via immunohistochemistry, green) overlays vGATE-assisted the ChR2-mCherry signal (red) in virtually all SON OT neurons of Dox-treated, osmotically challenged rats.
conditions: ± Dox and with or without salt loading (SL), which induced robust c-fos expression in OT neurons (Katoh et al., 2010; Figures 1B and 1C;  Table S1 ). Only under the +Dox/+SL condition, robust rtTA expression under a synthetic c-fos promoter was detected (red) within 24 h in roughly all of the OT neurons (Hamamura et al., 1991;  Figure 1C ). This result shows that the vGATE method is compatible with endogenous c-fos expression. With rAAV-P OT -Venus as a tracer, it was possible to verify proper virus targeting and spread of infection after injection.
In a different set of experiments, we injected a cocktail of three viruses called OT vGATE : (virus 1, rAAV-(tetO) 7 -P fos -rtTA; virus 2, rAAV-P tet bi-Cre/YC3.60; virus 3, rAAV-P OT -FLEX-humanized channel rhodopsin (hChR2)-mCherry) and analyzed for YC3.60 (virus 2) and hChR2-mCherry (virus 3). Under +SL/+Dox robust YC3.60 (P tet bi-Cre/YC3.60) and hChR2-mCherry (Cre-dependent, P OT -FLEX-hChR2-mCherry) immunosignals were co-localized in the majority of OT neurons (96.30% ± 1.88% SON, 97.22% ± 2.66% paraventricular nucleus (PVN); Figure 1D ). In these animals, we found that 2.4% ± 1.1% (48 of 2,011) of the YC3.60/hChR2-mCherry-expressing cells in the PVN and 5.7% ± 1.4% (132 of 2,320) of cells in the SON were non-OTergic (n = 6 animals). Under the +Dox /ÀSL ( Figure 1D ) condition, we found that 7.3% ± 2.2% YC3.60/hChR2-mCherry-positive cells around the SON were non-OTergic (179 of 2,450 neurons) and that 0.8% ± 0.5% YC3.60/hChR2-mCherry-positive cells around the PVN were non-OTergic (22 of 2,450 neurons, n = 6; n = animal number, 6 sections per animal). These unidentified YC3.60/ hChR2-mCherry-positive cells were within a radius of 400 mm from the border of the respective nucleus. Under ÀSL/ÀDox conditions ( Figure S1E ), we observed virtually no YC3.60 and mCherry labeling (0.1% ± 0.03%, 5 of 540 for the PVN; 0.3% ± 0.09%, 22 of 722 for the SON; n = 6, 6 sections per animal), a result of minimal leakiness of the P tet bi. Furthermore, we observed more than 93% (94.74% ± 1.75% for the SON and 93.56% ± 2.46% for the PVN; Table S1 ) co-localization of endogenous c-fos and mCherry in vGATE animals subjected to SL for 5 consecutive days ( Figure 1E ).
Optogenetic Stimulation of Tagged OT Neurons Reverses Freezing Behavior in Fear-Conditioned Rats
We investigated what fraction of the entire OT population actually contributes to the anxiolytic effect and how OT neurons are recruited during the expression of fear using contextual FC in rats ( Figure 2A ). We found that only a small number of OT neurons in the SON and PVN expressed c-fos during fear exposure ( Figures S2A and S2B ). Next we generated OT vGATE rats with bilateral injections of the vGATE viral cocktail to permanently tag activated OT neurons in the SON and PVN for activity manipulation by hChR2 (virus 1, rAAV-(tetO) 7 -P fos -rtTA; virus 2, rAAV-P tet bi-Cre/YC3.60; virus 3, rAAV-P OT -FLEX-hChR2-mCherry) (OT vGATE ). We specifically chose day 3 for the Dox injection because we wanted to exclusively label fear-activated OT neurons but not pain-sensitive OT neurons. As a control, we generated rats that constitutively expressed rAAV-delivered hChR2 in all OT neurons (OT Constitutive ) in the SON and PVN. Although the OT Constitutive group displayed viral expression in virtually all OT neurons (99.4% ± 0.8%, n = 4; Figure 2B1 ), in the OT vGATE group, only a small fraction of the OT neurons was tagged during fear expression (341 of 2,470, 13.8% ± 0.7% of OT neurons in the SON and 331 of 2,666, 12.4% ± 1.6% of OT neurons in the PVN) of $6,600 cells comprising the PVN and SON in rats (Althammer and Grinevich, 2017 ; Figure 2B2 ; Table S2 ). We found that only 1.2% of non-OTergic cells were labeled non-specifically (57 cells of 2,051 cells in total labeled via vGATE, PVN/SON combined, n = 4, 6 sections per animal) in the fearconditioned animals ( Figure S2C ). To determine whether OT vGATE neurons project axons terminating within the CeA subregion of the amygdala, we analyzed brain slices containing the CeL and found mCherry-positive fibers in the CeL that were also OT-immuno-positive ( Figure 2B2 ). Optogenetic stimulation of these OT axons in the CeL with blue light (BL) induced a prominent decrease in the freezing response (unfreezing) in both groups. Surprisingly, the BL-evoked unfreezing effect in the OT vGATE group was much stronger (freezing time, 6.9 ± 1.1 s versus 38.1 ± 7.6 s, p < 0.0001; Figure 2C2 ) and occurred faster (onset, 3.8 ± 0.7 s versus 25.9 ± 10.8 s, p < 0.0001; Figure 2D ) than in the OT Constitutive group (Figures 2C1 and 2D) . To rule out that the observed behavioral changes were mediated by brain regions other than the CeA, we injected 4 animals with rAAV-(tetO) 7 -P fos -rtTA, rAAV-P tet bi-Cre/YC3.60, and rAAV-P OT -FLEX-GFP. Four animals injected with rAAV-P OT -Venus served as a control. We analyzed the brains of the vGATE-injected animals and did not find any GFP-positive fibers outside of the CeA, whereas control animals showed prominent labeling of OT fibers in various brain regions, as reported previously ( Figure S2D ; Knobloch et al., 2012) . This indicates that fear-activated, vGATE-labeled OT neurons project exclusively to the CeA. In addition, we did not find a single mCherry-positive fiber in the CeA that was negative for OT immunoreactivity (n = 6 animals, 6 sections per animal, in which more than 15 mm of total axon length was analyzed), indicating that axonal projections from vGATE-labeled axons exclusively represent OT fibers. Conversely, we found no difference between OT Constitutive (98.2% ± 1.4%, n = 6) and OT vGATE (96.9% ± 2.1%, n = 6) groups regarding the labeling of OT-positive fibers in the CeL, indicating that all OT neurons projecting to the CeL are fear-sensitive. Next, to provide additional proof that OT vGATE neurons precisely project to the CeA, we injected green Retrobeads into the CeA of rats with OT vGATE neurons labeled by mCherry. The anatomical analysis revealed that 94.6% ± 3.1% of mCherry-positive OT neurons (1,337 OT vGATE neurons, PVN/SON combined, n = 4) contained green Retrobeads ( Figure S2E ), indicating that the vast majority of OT vGATE neurons project to the CeA.
Because our FC paradigm comprised an additional shock session (day 14, memory reinforcement) to achieve higher basal freezing rates, we wanted to rule out the possibility that this session leads to recruitment of new OT cells. Therefore, we performed another experiment in which animals were injected with rAAV-(tetO) 7 -P fos -rtTA and rAAV-P tet bi-Cre/YC3.60 and subjected to our FC paradigm (day 3 Dox injection, day 4 shock; Figure S2F ). On day 14, animals received an injection of rAAV-P OT -FLEX-hChr2-mCherry and were subjected to another round of FC 2 weeks later. Then one group received another Dox injection, and the control group was injected with saline one day prior to the additional shock session on day 29 ( Figure S2F ). Although the group that was injected with Dox twice displayed normal labeling (224 of 2,033, 11% ± 1.4% for the PVN; 260 of 1,940, 13.4% ± 1.7% for the SON; n = 5; Figure S2G ) of OT neurons, we only found a total of 11 mCherry-positive cells in the PVN (11 of 2,020, 0.5%, n = 5) and 17 mCherry-positive cells in the SON (17 of 2,177, 0.8%, n = 5) in the group receiving saline in the first round ( Figure S2G ). Thus, this experiment demonstrates that, after Dox has been cleared from the brain, only few additional OT cells get labeled. To verify that the comparable labeling of cells also held true on the axonal level, we compared OT-positive fibers within the CeA of animals perfused after 14 days with animals perfused after 43 days (2 weeks after the day 29 shock session; Figure S2F ) and found no difference in vGATE-mediated labeling (day 14: 96.9% ± 2.1%, n = 6; day 43: 95.3% ± 3.1%, n = 6). Because a recent study highlighted the existence of freezingpromoting (somatostatin-ergic) and flight-promoting (corticotropin-releasing hormone-ergic) neurons (Fadok et al., 2017) , we sought to find out which cell types within the CeL are activated upon BL stimulation. Therefore, we injected rats with our vGATE viruses (rAAV-(tetO) 7 -P fos -rtTA and rAAV-P tet bi-Cre/ YC3.60) and either rAAV-P OT -FLEX-Venus (n = 4) or rAAV-P OT -FLEX-hChr2-mCherry (n = 4) and subjected them to our FC protocol ( Figure 2A) . On day 15, we illuminated the CeL for 2 min and sacrificed animals 90 min later. We found that fear exposure itself did not cause c-fos expression in the CeL, whereas BL stimulation robustly induced c-fos in this structure. In the BL-stimulated animals, we counted 888 corticotropinreleasing hormone (CRH)-positive neurons and 290 SOMpositive neurons, whereas 104 neurons expressed both markers. 84% ± 3.6% of exclusively SOM-positive neurons, 11% ± 0.9% of exclusively CRH-positive neurons, and 58% ± 4.3% of the mixed population expressed c-fos ( Figure S2H ). Thus, these findings suggest that OT release in the CeL predominantly activates SOM-positive interneurons.
Fear-Experience-Dependent Anatomical and Functional Plasticity of Hypothalamic OT Neurons Projecting to the CeA To investigate potential anatomical and molecular changes following fear experience, we generated OT vGATE rats (virus 3, rAAV-P OT -FLEX-GFP) and quantitatively analyzed OT axons within the CeL. In parallel, we analyzed fear-naive rats expressing P OT -Venus for constitutive labeling of all OT neurons (OT Constitutive ; Figure 3A1 ). Although the total length of axonal segments was similar in both groups ( Figure 3A3 ), there was a substantial increase ($3-fold) in the numbers of GFP-positive axonal varicosities containing immunosignals of vesicular glutamate transporter 2 (vGluT2) in the OT vGATE group ( Figure 3A3 ; Table S3 ). Furthermore, we found that the detectable OT levels in vGATE fibers were at least 3-fold lower compared with the fear-naive animals injected with P OT -Venus, potentially resulting from the enhanced glutamate expression (fear-naïve, 58.0% ± 8.4%; fear-experienced, 15.3% ± 3.1%; signal intensity, n = 4; 6 sections per animal; Figure S3A ). To elucidate the seemingly counter-intuitive observation that activation of a small subset of OT neurons resulted in a stronger behavioral response than activation of axons originating from virtually all OT neurons (OT Constitutive group) in the CeL, we next aimed to investigate the underlying circuitry within the CeA by ex vivo electrophysiology in acute brain slices from fear-naive OT Constitutive and fear-experienced OT vGATE groups ( Figure 2D ). In the naive group, all OT neurons constitutively expressed hChR2 (OT Constitutive ), whereas in the OT vGATE group, a small fraction of OT neurons was labeled with the vGATE virus cocktail (virus 3, P OT -FLEX-hChr2-mCherry). In both groups, BL stimulation of OT axons in the CeL ( Figure 3B ) induced an increase in inhibitory postsynaptic current (IPSC) frequencies in neurons of the CeM, which receive direct synaptic input from GABAergic neurons of the CeL ( Figure 3C1 ). Interestingly, the BL-induced increase in CeM IPSC frequencies in the OT vGATE group was almost entirely blocked by the glutamate AMPA receptor antagonist NBQX, whereas it only had a minor effect on the control group ( Figure 3C2 ). On the other hand, the application of the OT receptor antagonist dOVT diminished the BL-induced increase in CeM IPSCs in the OT vGATE group by only 50%, whereas it prevented the increase in CeM IPSCs in the control OT Constitutive group entirely ( Figure 3C2 ).
To rule out that the observed differences were not a result of the fear experience, we injected an additional group of animals with rAAV-P OT -hChR2-mCherry (OT Constitutive ) and subjected them to the same paradigm as the OT vGATE group ( suggest that the initial exposure to FC induced plastic changes in OT neurons, resulting in prevalent release of glutamate from their axonal terminals within the CeL. Because of the similarity of behavioral and amygdala responses to OT axon stimulation in fear-experienced OT Constitutive and OT vGATE groups, the observed effects might stem from the same population of OT neurons naturally activated in both groups of rats during fear expression ( Figure 2B ). To test whether the ex vivo findings have a functional relevance in vivo, we blocked the OT receptor specifically with an antagonist (OTA, L-368,899, 1 mg/kg intraperitoneally [i.p.]) that crosses the blood-brain barrier (Eliava et al., 2016) . First, we injected rats bilaterally in the SON and PVN with P OT -hChR2-mCherry (OT Constitutive ) for optogenetic tagging and implanted optic fibers into the CeA ( Figure 3D1 ). Next we subjected the animals to the FC paradigm. On day 3, treatment of the animals with OTA 40 min prior to BL stimulation (session 1, OTA + BL1) completely prevented the BL-induced unfreezing effect ( Figure 3D2 ). However, 2 weeks later, when we exposed the very same animals to the second session of FC (session 2, OTA + BL2), the animals displayed a rapid BL-induced unfreezing response despite prior application of OTA ( Figure 3D3 ). Interestingly, the onset of BL-induced unfreezing occurred much faster (6 ± 0.8 s versus 25.9 ± 10.8 s, p < 0.0001; Figure 3D4 ) than in the fear-naive OT Constitutive group ( Figure 2D ). To exclude that the observed unfreezing effects were a result of OTA-induced changes in plasticity originating from the first round of FC, we processed an additional group of animals constitutively expressing hChR2 in OT neurons, which received saline (instead of OTA) in the first session and OTA in the second session, and obtained similar results ( Figures S3C1-S3C3 ) as in the initial group, which was treated with OTA in both sessions ( Figure 3D ). Thus, our data indicate that fear experience drives a shift from OT to glutamate release from OT axons in the CeL of fearexperienced groups. Moreover, the enhanced responsiveness of CeL neurons to glutamate and its correlated effect, which could be abolished by application of NBQX ( Figure 3C2 ), may indicate a transient, fear-experience-induced upregulation of AMPA receptors in these cells.
Inhibition of Fear-Activated OT Neurons Impairs Fear Extinction in a Context-Dependent Manner
To provide further evidence that OT neurons activated by fear exposure attenuate fear expression, we hypothesized that silencing of OT vGATE neurons inhibits fear extinction specifically in the context where these neurons had originally been activated. Therefore, rats (n = 6) were injected with a virus expressing the Virally injected animals were subjected to contextual FC. After two shock sessions (day 1 and day 2), animals received an i.p. injection of Dox on day 3, followed by another session on day 4 without shocks. Ten days later, animals were subjected to an additional shock day to reinforce the fear memory and then underwent a 4-day fear extinction protocol. During the extinction session, animals received a daily injection of CNO 40 min prior to the experiment. After exposure to context B, animals were subjected to 2 days of shock, followed by another 4-day extinction session, where they again received CNO daily prior to the experiment. modified human muscarinic receptor hM4D(Gi) under control of the OT promoter exposed to contextual FC and extinction paradigms ( Figure 4A ). All four groups of animals (OT vGATE A-A, OT vGATE A-B, OT Constitutive A-A, and OT Constitutive A-B) were subjected to FC in context A (day 1 shock, day 2 shock, day 3 Dox injection, day 4 exposure). To induce fear extinction, the two groups (OT vGATE A-A and OT Constitutive A-A) were exposed to the same context A for four consecutive days (40 min each session) without any electrical shock, receiving a daily i.p. injection of clozapine-N-oxide (CNO) 40 min prior to testing (control groups received saline). In parallel, we processed two additional groups of animals (OT vGATE A-B and OT Constitutive A-B, n = 6) in analogy to the first groups that were submitted to a first round of FC (in context A) and then transferred to a novel context (context B; Figure 4 , blue star) prior to being submitted to the extinction protocol. We introduced the novel context (context B) to specifically investigate the potential role of OT in context-dependent fear extinction. This context represented a novel environment that was distinct in terms of visual, tactile, and olfactory cues ( Figure S4A ). Importantly, rats conditioned in context A did not display contextual FC in context B ( Figure S4B ), clearly demonstrating that animals are able to discriminate between the two boxes (the complete dataset on freezing behavior is provided in Table S4 ).
Silencing of all OT neurons by constitutively expressed hM4D(Gi) and application of its agonist CNO resulted in impaired fear extinction in both contexts A and B ( Figure 4B1 ; Table S4 ). We next applied the vGATE technique to express hM4D(Gi) specifically in OT neurons (virus 3, rAAV-P OT -hM4D-Gi). We discovered that the silencing of OT fear neurons that were tagged in context A impaired fear extinction in context A but not in the novel context B ( Figure 4B2 ). Because CNO has been reported to potentially activate certain neurons (Gomez et al., 2017) , we performed control experiments (without virus injection, n = 6), where CNO alone had no effect on context-specific fear extinction ( Figure S4C ). To further rule out that the observed differences in fear extinction dynamics were a result of the two different contexts, we subjected naive, non-injected animals to fear extinction sessions in both contexts and found comparable freezing times throughout the extinction sessions (n = 6; Figure S4D ). To demonstrate that the observed impairments in fear extinction stem from inhibition of local OT release onto the CeA, we injected rats (n = 8) with the vGATE cocktail (virus 3, rAAV-P OThM4D-Gi) and implanted bilateral guide cannulas above the CeA for local infusion of CNO ( Figures 4C1-4C2 ). CeA local infusion of 1 mM CNO (Stachniak et al., 2014) 15 min prior to each session impaired fear extinction in context A but not context B ( Figure 4C3 ), confirming our previous results. To verify proper targeting of the CeA, we infused Retrobeads immediately after the last extinction session and killed the animals 10 min later to avoid spreading of the tracer ( Figure 4C2 ). The control group (n = 8) injected with vGATE-GFP viruses displayed normal fear extinction in both contexts, indicating that local infusion of CNO per se does not impair fear extinction ( Figure 4C3 ).
Activity of OT Neurons in the SON Is Context Dependent
To shed light on the cellular mechanisms underlying the contextdependent effect of neuronal inhibition ( Figure 4B2 ), we labeled the OT vGATE neurons green with the rAAV-P OT -FLEX-GFP (virus 3) and co-stained sections for endogenous c-fos red to identify the fraction of OT cells that was active during re-exposure to the same context ( Figure 5A ). In line with previous results (Figure 2B2 ), the first round of context A FC induced tagging of 10.8% of OT neurons in the PVN and 11.9% in the SON, visualized by intrinsic GFP ( Figure 5A ). The second round of context A FC induced c-fos signal in 9.5% of OT neurons in the PVN and 16.2% in the SON ( Figure 5A ). The overlap of virally expressed GFP and c-fos was 18% in the PVN and 89% in the SON, suggesting context-dependent activity of OT neurons specifically in the SON as well as a functional difference between the two nuclei. The difference in re-activation of OT cells in context A/A versus context A/B was significant for the SON (context A-A, 89% ± 5.5%; context A-B, 22% ± 3.6%; n = 6, p < 0.0001) but not the PVN (context A-A, 18% ± 2.7%; context A-B, 31% ± 3.7%; n = 6, p = 0.2805; Table S5 ). It is important to note that the group of animals that was first exposed to context A displayed $5 times more activated neurons in both the PVN and SON after further exposure to context B (PVN: context A vGATE-GFP, 9.6%; context B c-fos, 47.1%; SON: context A vGATE-GFP, 11.7%; context B c-fos, 56.4%; Figure 5B ; Table S5 ). This 5-fold difference in neuronal OT activity in context B correlated with the dramatically increased OT concentration in the blood (27.64% ± 5.4% pmol/mL versus 86.7% ± 12.9% pmol/mL; Figure S5A) . However, despite the massive recruitment of new cells, the overlap of GFP-positive and c-fos-expressing OT neurons in the SON in context B amounted to only 22%. Taken together, these results indicate that re-exposure to a familiar FC context reactivates the same fraction of OT neurons, whereas exposure to a novel context recruits an entirely different population of cells. Therefore, it is plausible that OT neurons participate in a longlasting fear memory engram that coordinates the OT-ergic response to different contextual fear episodes. Finally, to investigate whether OT engram cells display basic electrophysiological properties distinct from non-engram OT cells, we performed an additional experiment where we injected animals (n = 12) with vGATE (virus 3, P OT -FLEX-GFP) and P OTmCherryChr2 into the SON only. Animals were fear-conditioned, received an injection of Dox on day 3, and were processed for ex vivo patch-clamp recordings. In these animals, non-engram OT cells expressed red fluorescence, whereas vGATE-labeled engram cells appeared in yellow (green + red) ( Figure 5C1 ). We analyzed access resistance, membrane capacitance, membrane potential, spontaneous excitatory postsynaptic current (EPSC) amplitudes and frequencies, and discharge profile upon current steps. Interestingly, we found significant differences in membrane capacitance (OT non-engram: 20.81 ± 1.25 pF, n = 16; OT engram: 26.13 ± 1.52 pF, n = 24; p < 0.05; Figure 5C2 ) and frequency of spontaneous EPSCs (OT nonengram, 1.87 ± 0.51; OT engram, 3.18 ± 0.54 Hz; p < 0.05; Figure 5C2 ). All other parameters did not significantly differ between OT Constitutive and OT vGATE cells ( Figure S5B ). Thus, these findings suggest that vGATE-labeled OT engram cells have a larger membrane surface and receive more excitatory inputs, a feature of engram cells that has already been described for the hippocampus (Kitamura et al., 2017; Ryan et al., 2015) . To investigate whether increased glutamatergic input onto OT vGATE could potentially underlie the observed differences in membrane capacitance and increased spontaneous EPSCs, we stained brain slices of vGATE-injected rats with the vesicular glutamate transporter vGluT2 and compared the number of vGluT2-positive puncta in the immediate surroundings (surface of soma and 5-mm radius around each OT-positive neuron). We found that the number of vGluT2 puncta encompassing the OT engram (OT vGATE ) cells (18.6 ± 1.2, 130 cells, n = 3) was significantly higher (p < 0.001) compared with non-engram OT neurons (8.3 ± 0.9, 1,044 cells, n = 3) ( Figure 5C3 ). These results suggest that OT engram cells receive more prominent glutamatergic input than OT non-engram cells, potentially explaining the unique electrophysiological properties of engram OT neurons ( Figure 5C2 ).
Parvocellular OT Neurons Activate Magnocellular OT Neurons in a Novel Context
Because the OT system is composed of two types of neurons, magnocellular (magnOT) and parvocellular (parvOT) neurons (Rhodes et al., 1981; Swanson and Kuypers, 1980; Swanson and Sawchenko, 1983) , we next aimed to investigate which hypothalamic OT cell types are reactivated during the two fear episodes. To distinguish between magnOT and parvOT neurons, we used the retrograde marker Fluorogold (FG), which labels magnOT but not parvOT cells (Naumann et al., 2000) . Injecting the cocktail of vGATE viruses (virus 3, rAAV-P OT -FLEX-GFP), we found that virtually all FG-negative parvOT neurons of the PVN (parvOT neurons are not present in the SON) were labeled with GFP in context A and contained c-fos in context B, whereas only a small fraction (14%-20%) of FGpositive magnOT neurons of the PVN and SON labeled with GFP in context A were c-fos positive in context B ( Figure 6A ; Table S6 ). Following previous findings that PVN parvOT neurons provide synaptic inputs onto OT neurons in the SON to activate magnOT neurons (Eliava et al., 2016) , we aimed to silence parvOT neurons to elucidate their functional relevance in the novel context B during repeated fear exposure. To achieve this, we expressed hM4D(Gi) in a Cre-dependent manner in the PVN via a CAV2-Cre virus injected into the SON ( Figure 6B ) to silence parvOT inputs onto magnOT neurons. We found that silencing of parvOT neurons in context B prevented the massive induction of c-fos expression in the SON (Figures 6C-6G ; Table S6 ), indicating a critical role of parvOT neurons during repeated fear exposure. Similar results were obtained in the PVN (Figures S6A-S6E ), suggesting that parvOT neurons might also directly or indirectly control magnOT activity within PVN neurons. To exclude that the prevented rise in c-fos expression was a result of CNO treatment, we subjected animals to the same paradigm, where they received CNO but were not injected with Cre-dependent hM4D(Gi) rAAV, and found no differences in c-fos expression in OT neurons of the SON and PVN ( Figure S6F ).
DISCUSSION
Here we provide first evidence that vGATE-assisted OT-tagged neurons during fear expression are sufficient for controlling fear behavior and necessary for fear extinction. Furthermore, fear experience drives enormous plasticity, mediating a shift from OT to glutamate signaling in the CeL. We propose that repeated fear exposure activates OT-ergic fear engram cells for rapid adaptive behavioral responses.
The Context-Dependent Fear Memory Engram and Its Plasticity in the Hypothalamic OT System
The hypothesis that learning-activated cell ensembles form memory engrams has received substantial attention (Kitamura et al., 2017; Liu et al., 2012; Reijmers et al., 2007) . Although memory engrams have been discovered in higher brain regions such as the cortex, hippocampus, or basolateral amygdala (Kitamura et al., 2017; Liu et al., 2012) , no study, to our knowledge, has addressed the potential role of the lower brain regions, such as the hypothalamus, in the modulation of fear memory. In a number of studies, the OT system has been highlighted as a key structure modulating various aspects of fear, such as acquisition, expression, and extinction.
To investigate whether OT neurons encode for contextspecificity, we applied the vGATE method to identify and manipulate potential OT engram cells and labeled a small fraction ($11%-14%) of hypothalamic OT neurons by contextual FC. Remarkably, the majority of OT vGATE neurons project to the CeA, and optogenetic activation of the OT neuronal axonal fibers in the CeA elicited rapid onset of unfreezing. We further found that, upon fear exposure, OT neurons show enhanced glutamatergic over OT-ergic transmission in the CeM ( Figure 3D1 ) with increased membrane capacitance ( Figure 5C2 ) and elevated vGluT2-levels in OT axons terminating in the CeA ( Figure 5C3 ), consistent with previous studies (Ciocchi et al., 2010; Li et al., 2013; Penzo et al., 2015) . Thus, our results provide the first evidence for fear-induced long-term plasticity (15 days) of the OT-CeL circuit. It seems indeed possible that a single episode of fear conditioning permanently alters the OT and glutamate balance, perhaps to strengthen synaptic connections for rapid response and memory maintenance. These findings support the general notion that coordinated release of slow-acting neuromodulator peptides and fast-acting amino acid transmitters could be a likely mechanism to modulate cognitive, emotional, and metabolic processes (van den Pol, 2012). Based on our findings, we hypothesized that OT vGATE engram neurons might also be involved in fear extinction. Given the key role of CeA in fear extinction, we next investigated whether context-specific OT neuronal circuits would control contextspecific fear extinction. Although inhibition of virtually all OT neurons resulted in context-independent impairment of fear extinction, inhibition of OT vGATE neurons exclusively affected fear extinction in the context in which the cells had originally been labeled. These OT vGATE neurons might be required for suppression of memory expression, safety cues, and priming for extinction. This could explain the unaffected fear extinction of animals in context B after silencing of OT vGATE neurons that were tagged in context A, where inhibition of these fibers might no longer be relevant, because newly recruited OT neurons in a different context could compensate for the reduced release of OT in the CeA by release of this neuropeptide in other brain regions ( Figures 4B2 and 4C3) . Therefore, we concluded that silencing of OT vGATE engram cells impaired fear extinction, demonstrating necessity, a likely result of blocking OT and glutamate-mediated neural modulation in the CeA. We propose that OT vGATE cells represent a ''neuromodulatory'' engram that plays a vital role in controlling simple ''contextual memory'' representations for context-specific behavioral expression and the extinction phenotype.
Context-Independent Control by
Parvocellular OT Neurons of the Hypothalamic OT System OT neurons are divided into two types: magnOT and parvOT neurons. Despite their relatively low numbers ($70 neurons per rat), parvOT neurons modulate important physiological processes, such as cardiovascular functions, hunger, and pain (Althammer and Grinevich, 2017) . The present study highlights the functional relevance of parvOT neurons in contextual FC because virtually all parvOT neurons that were activated in context A were also reactivated in context B, and silencing of parvOT neurons almost entirely blocked the recruitment of novel magnOT neurons in an unfamiliar context. Therefore, we hypothesize that parvOT neurons operate as a class of ''master cells,'' orchestrating magnOT neuron activity and subsequent OT release into the blood. Although the precise role of OT neurons during fear conditioning remains to be determined, it is plausible that the coordinated activity of parvOT neurons may facilitate global priming effects and/or induce plasticity of magnOT neurons in various physiological demands (Theodosis et al., 1986; Tobin et al., 2012) . In line with this, global activation of the OT system, driven by parvOT neurons, can be crucial for metabolic, autonomic, and behavioral adaption to exacerbated fearinduced stress. In our current study, the 5-fold increase in c-fos expression quite accurately matches the 5-fold elevation of OT levels in the blood ( Figure S6A ). This indicates that newly activated OT neurons in context B are magnOT cells that release the neuropeptide from the neurohypophysis into the blood.
Thus, the newly recruited OT neurons in both hypothalamic nuclei provide a massive release of OT into the peripheral circulation to regulate various physiological demands to cope with an exacerbated stress response (Yang et al., 2013) .
Conclusion
We identified and validated a neuromodulatory engram composed specifically of OT cells that fulfills the key criteria of the synaptic plasticity memory hypothesis (Martin et al., 2000) : sufficiency, necessity, and plasticity. We demonstrated that OT neurons of the SON participate in a fear memory engram (Figure 7) , whereas parvOT neurons coordinate OT release in a context-independent manner. Our findings will facilitate the investigation of pathophysiological mechanisms underlying emotion-associated mental disorders, especially PTSD symptoms, their potential treatment by exogenous OT (Althammer et al., 2018; Frijling et al., 2014) , and virus-delivered genetically based targeted therapeutic agents.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Animals
Anatomical, electrophysiological, optogenetic and behavioral studies were performed with female Wistar rats purchased from Janvier, France (8-10 weeks old on arrival at our facility). All rats were housed under standard conditions with ad libitum access to food and water. All experiments have been approved by the German Animal Ethics Committee of the Baden W€ urttemberg (licenses numbers 35-9185.81/G-24/12, 35-9185.81/G-26/15 and 35-9185.81G-102/17 ) and the French Ministry of Research (APAFIS#3668-2016011815445431 v2).
METHOD DETAILS
The vGATE system Generation and cloning We engineered a synthetic c-fos promoter linked to its first exon (Exon 1; (Schilling et al., 1991) with ATGs in the Exon 1 converted to TTGs by site directed mutagenesis and heptamerized tetracycline (tet) operators, (tetO) 7 , added upstream of it. These operators drive the expression of a humanized reverse tet transactivator (rtTA) (Dogbevia et al., 2015) named (tetO) 7 -P fos -rtTA. The entire cassette was subsequently cloned in a plasmid to produce recombinant adeno-associated viruses (rAAVs) packaged with serotype 1 and 2 (Dogbevia et al., 2015) to generate Virus1 (rAAV-(tetO) 7 -P fos -rtTA). Next, an AAV equipped with bidirectional tet promoter (P tet bi) expressing the Cre-recombinase was linked to a genetically-encoded calcium indicator (YC3.60) (Virus 2, rAAV-P tet bi-Cre/YC3.60, (L€ utcke et al., 2010) ). As the last component of our viral technique (Virus 3), we generated rAAVs under the OT promoter to drive expression of hChR2-mCherry, GFP or hM4D(Gi)-mCherry (Eliava et al., 2016; Grund et al., 2017) in a Cre-dependent manner. The entire system comprising rAAV-(tetO) 7 -P fos -rtTA (Virus 1), as the key element of the system, combined with rAAV-P tet biCre/YC3.60 (Virus 2) and the Cre-dependent 'FLEX' viruses (Virus 3, see Key Resources Table) for 'virus-delivered, Genetic Activity-dependent Tagging of cell Ensembles' or vGATE. In the vGATE method, the c-fos promoter drives rtTA expression only when neurons are activated. The rtTA generated by transient c-fos promoter activity binds to the upstream (tetO) 7 only in the presence of Dox. This way, the rtTA drives its own expression, thus establishing an autoregulatory loop, even when the induced c-fos promoter activity declines to baseline levels as neuronal activity subsides. Therefore, only in the presence of Dox, the rtTA can activate the expression of the bidirectional tet promoter (P tet bi) to express any gene of choice, for example, the Cre recombinase, for permanent tagging of activated cells via a Cre-dependent FLEX cassette.
Validating in cultured neurons
Dissociated rat hippocampal cultured neurons were treated with two viruses (rAAV-(tetO) 7 -P fos -rtTA + rAAV-P tet bi-Cre/tdTOM) for two weeks. Afterward, cells were treated with bicuculline (bic) for 20 min and replaced with fresh medium supplemented with Dox (1 mg/ml) for 24 h. Only in the presence of bic and Dox, a strong rtTA signal was detected by immunohistochemistry ( Figure S1 , bottom panel). By live fluorescence imaging of fixed cells, rtTA-dependent tdTOM expression was also clearly detected in +bic/+Dox treated cells. In a few neurons, however, tdTOM expression was also detected under condition of -bic/+Dox. This is likely a result of spontaneous activity in some neurons. Western blot analyses validated tdTOM expression ( Figure S1 ).
Novelty of the method
We describe here a genetic method (vGATE) that uses c-fos promoter elements to drive expression of a reverse tetracycline transactivator (rtTA). The key novelty of our method is that the 'recording period' can be rapidly opened within a few hours by a single intraperitoneal Dox injection before the tagging of activated neurons. In previous methodological studies, we carefully characterized, both ex vivo and in vivo, the regulation of Dox-controlled gene expression by rtTA expressed under a human synapsin promoter (Dogbevia et al., 2015; Dogbevia et al., 2016) . We determined an optimal Dox concentration for in vivo application, and the time course of gene activation and inactivation by a single intraperitoneal Dox injection. In our previous studies, we found that the bidirectional Tet promoter (P tet bi) has highly reduced leakiness (Dogbevia et al., 2016) compared to the uni-directional Tet promoter (P tet ) (Dogbevia et al., 2015) . Indeed, P tet is very leaky (Dogbevia et al., 2015) , due to its close proximity close to an inverted terminal repeat (ITR) of AAV, which appears to have intrinsic enhancer-like activity (Dogbevia et al., 2015) . This raises potential concerns that AAVs equipped with a uni-directional tet promoter (P tet ) might be leaky enough to non-specifically tag non-engram cells. With these considerations, we characterized the vGATE method both ex vivo and in vivo. The vGATE method is very tightly controlled and highly flexible; different combination of gene modules in rAAVs can be simultaneously delivered to the targeted brain region(s). With this approach, we performed selective and cell-type-specific tagging of OT neurons activated during contextual fear learning and expressed in the tagged neurons gene(s)-of-interest for pharmacogenetic and optogenetic manipulations, while others might easily target different neuronal populations. Different methods exist to induce time-dependent conditional protein expression, namely the TetTag (Reijmers et al., 2007) and the TRAP (Guenthner et al., 2013) methods. The TetTag method drives tTA expression under c-fos and animals have to be fed Dox to keep the system inactive. However, to open the recording period, TeTag animals have to be switched to diet without Dox for a few days before performing learning-dependent neuronal labeling. However, this non-recording period of a few days is sensitive for non-specific labeling of neurons. In the case of vGATE, the presence of Dox is requested to activate detectable gene expression within a few hours and achieved the maximum expression after 24 h (Dogbevia et al., 2015 (Dogbevia et al., , 2016 and gene expression is switched-off in 6 days (Dogbevia et al., 2016) . In a previous systematic study (Dogbevia et al., 2016) , we found similar time course of 6 days to ''re-activate'' (with the tTA system) by Dox removal and ''activate'' (with the rtTA system) gene expression by Dox addition. The discrepancy for 3 days for Dox clearance by others using the tTA system is likely due to the sensitivity of the detection method; we used a highly sensitive reporter, the firefly luciferase, for gene expression assay as a proxy for Dox clearance from the brain (Dogbevia et al., 2016) , while other labs use GFP (Liu et al., 2012) , which are much less sensitive.
In the TRAP method, the inducer, tamoxifen, is needed to facilitate release cytoplasmic ER-Cre for transport to the nucleus to permanently tag neurons by Cre/loxP dependent gene modules. However, TRAP is in itself leaking, since it is known that a fraction of ER-Cre can already move to the nucleus even without tamoxifen treatment. There is even a bigger concern that tamoxifen as a selective estrogen modulator might interfere with various estrogen-sensitive cell types in the brain. The use of tamoxifen is especially critical for OT neurons, which are sensitive for estrogens (Somponpun and Sladek, 2003) and tamoxifen itself triggers the activity of the OT gene promoter (Koohi et al., 2005) . Finally, tamoxifen induces c-fos expression in OT neurons (F.A. and V.G., unpublished data), thereby precluding the use of the ER-Cre method for this particular neuron type. With our novel vGATE technique, we achieved highly specific labeling of OT neurons and precise temporal control, which we believe to be superior to other comparable, c-fos based tagging methods. Therefore, the development of the vGATE method should be able to overcomes the key inherent concerns of the previous two main strategies to induce time-dependent conditional protein expression.
Infecting rat hypothalamic neurons in vivo with rAAVs Cloning of the OT promoter, as well as the production and purification of rAAVs, has been previously described (Knobloch et al., 2012) . rAAV genomic titers were determined with QuickTiter AAV Quantitation Kit (Cell Biolabs, San Diego, California, USA) and RT-PCR using the ABI 7700 cycler (Applied Biosystems, California, USA). rAAVs titers were between 10 10 -10 11 genomic copies per 1 ml. Infection of OT neurons was achieved by complementing the two viruses indicated above by an rAAV, driving genes of interest (Venus, hChR2-mCherry, FLEX-GFP, FLEX-hM4D and hM4D(Gi). A cocktail of the three rAAVs (i.e., rAAV-(tetO) 7 -P fos -rtTA, rAAV-P tet bi-Cre/YC3.60, and rAAV-P OT -Venus) was injected bilaterally into the hypothalamic nuclei, the PVN and SON, using a previously described protocol (Knobloch et al., 2012) .
Neuroanatomy
To trace, label and manipulate the hypothalamus-amygdala connections, rAAVs expressing vGATE viruses were injected into the PVN and SON. Alternatively, CAV2-Cre was injected into the SON, while the Cre-dependent ''FLEX'' P OT -hM4D(Gi) rAAV was injected into the PVN to specifically label and manipulate parvOT neurons. After transcardial perfusion with 4% PFA, brains were sectioned and stained with antibodies against OT, vGluT2, GFP, FG and dsRed. Images for qualitative and quantitative analyses were taken on the confocal microscope Leica SP5.
BEHAVIOR
Salt loading
To validate the vGATE system in vivo, we performed salt-loading (SL) as a stimulus to activate c-fos expression in OT neurons (Katoh et al., 2010) . Here, we used a mixture of two rAAVs (rAAV-(tetO) 7 -P fos -rtTA and rAAV-P OT -Venus) and co-injected them unilaterally into the SON of rats. The animals were divided into four groups (n = 3/group): Group 1 (Untreated control animals (-Dox/-SL)), Group 2 (-Dox/+SL, 7 days with SL (2% NaCl in drinking water), Group 3 (+Dox/-SL, normally hydrated animals, which received single Dox i.p. injection) and Group 4 (+Dox/+SL, animals received a single i.p. injection of Dox on the 5 th day of SL and were kept under SL for 2 more days before being sacrificed). Expression patterns of the individual groups are depicted in Figure 1D .
Contextual fear conditioning and optogenetics
We used a mixture of three vGATE viruses as depicted ( Figure 1A) . Two weeks after the viral infection, adult female rats were subjected to either a 3-day (single fear) or 15-day (double fear) contextual fear conditioning protocol, comprising a conditioning session on the first 2 days and a recall session on the 3rd day ( Figure 2A ). All sessions lasted for 20 min with 7 random foot shocks (1.6mA, 1 s) dispersed between the 10 th and 17 th min of protocol during the fear conditioning session.
As shown in Figure 2A , animals were treated with Dox (5 mg/kg b.w., i.p.) 24 h after the 2 nd day of fear acquisition to tag OT neurons activated during fear expression. The experimental group (animals injected with the vGATE system: rAAV-(tetO) 7 -P fos -rtTA + rAAV-P tet bi-Cre/YC3.60 + rAAV-P OT -FLEX-hChR2-mCherry) received another re-conditioning session (double fear), two weeks after Dox injection and recovery, for one day, to achieve a higher level of freezing (above 50 s/min) and 24 h later were tested for the recall of fear behavior with blue light (BL) illumination of the CeA. The CeA was illuminated bilaterally with BL (473 nm, 10 ms pulse, 20 s duration, 30 Hz) via 200 mm optical fibers from Thorlabs (BFL37 200) at the 10 th min of the recall session. The rats were evaluated for freezing responses and freezing durations were measured through freezing software (Panlab) and manually through an offline video in addition. In Figure 2C , the 2 different graphs display the average freezing time per minute in the corresponding groups (OT Constitutive and OT vGATE ) before and after BL illumination. The black bars (control) show the average freezing times in minutes immediately prior to the BL illumination, whereas the gray bars (BL) indicate the average freezing times per minute during the minute in which the BL-induced onset of the unfreezing effect (i.e., where the first signs of mobility appear). All groups of animals were sacrificed 90 min after the start of the optogenetic session. Estimation of the estrous cycle To monitor ovarian cycle, we performed vaginal smear collections. Animals in metestus, proestrus and estrus phases were excluded from experiments and reintroduced once they reached diestrus. Pharmacogenetics (DREADD) and fear extinction in Contexts A and B In this experiment, animals were subjected to a series of fear conditioning and fear extinction paradigms that we performed in two different contexts (A and B). For this purpose, two visually distinct contextual fear conditioning chambers were used, which were comparable in size, shape of the grid and power of the electrical shocks (1.6 mA). The chambers were located in two different institutes (chamber A, Max Planck Institute of Medical Research (MPI), Heidelberg, Panlab; chamber B, Interdisciplinary Neurobehavioral Core (INBC), Heidelberg, Med Associates) and the animals were exposed to them for the first time in both cases. Animals were injected with P OT -hM4D(Gi) (OT Constitutive ) or rAAV-(tetO) 7 -P fos -rtTA, rAAV-P tet bi-Cre/YC3.60 + rAAV-P OT -FLEX-hM4D(Gi) (OT vGATE ) and subjected to the experimental procedure after recovery and handling. For the contextual fear conditioning, animals were placed in a fear conditioning chamber (Panlab, Harvard Apparatus) with a metal grid for application of electrical foot shocks (1.6 mA). We used a 3-day fear conditioning protocol (2 days shock, 1 day testing, each 20 min) to fear condition the animals. On the first two days, the animals, after a 10 min habituation period, received 7 electrical foot shocks within 7 min (randomly distributed, on average 1 shock per min), followed again by 3 min without shocks. For activation of the viral system, animals received Dox (5 mg/kg b.w., i.p.) on day 3 of the fear conditioning (24 h after the 2nd shock day of the first round of fear conditioning). On the fourth day (24 h after injection), animals were placed in the same box for 20 min without any shocks. The experiment was recorded with a video camera and sensors in the grid measured the total movement of the animals during the procedure. After a 2-week break (Dox clearance and viral expression) animals were exposed to the box in a second session. Here, we used a 5-day fear extinction protocol with one reconditioning day (in order to maintain a high level of freezing (above 50 s/min) and identical in all groups) and 4 testing days. Due to the 2-week interval in between the two rounds, animals received electrical shocks on the first day (recall session), followed by 4 days on which the animals were placed in the box for 40 min each without any shocks (extinction sessions). Animals expressing the hMD4D(Gi) receptor in all OT neurons (OT Constitutive ) or tagged OT neurons (OT vGATE ) received a daily injection of Clozapine (3 mg/ kg bw i.p., Tocris Bioscience, Bristol, UK, dissolved in 1xPBS) 30 min prior to placing them into the Context A chamber. The control groups (OT Constitutive and OT vGATE ) received the same volume of 0.9% NaCl solution. After the first round of fear extinction in Context A, animals were transferred to Context B. Here, an additional round of fear extinction was performed, which comprised two shock sessions followed by 4 consecutive daily extinction sessions, 40 min prior to which the animals received a daily injection of CNO (Figure 4A) , whereas the control group received the same volume of 0.9% NaCl solution 40 min prior to the start of the session. All animals were sacrificed and perfused 90 mins after the fear conditioning session in Context B. In the two control groups, the time of freezing in both contexts was almost identical ( Figure S4B ). Therefore, for the sake of simplicity, only the freezing time of OT Constitutive and OT vGATE control groups in Context A is depicted in Figures 4B1 and 4B2 . Context A versus Context A -mapping of OT neuronal activity via GFP followed by immunostaining for c-fos Animals were injected in all nuclei with the vGATE system (rAAV-(tetO) 7 -P fos -rtTA + rAAV-P tet bi-Cre/YC3.60 + rAAV-P OT -FLEX-GFP) and subjected to the 3-day contextual fear conditioning paradigm after recovery and handling. Following the first two shock sessions, animals received Dox (5 mg/kg b.w., i.p.) on the 3 rd day of the fear conditioning paradigm. On the 4 th day, animals were exposed to the fear conditioning chamber, this time without electrical shocks. Two weeks after the 1 st round of fear conditioning in Context A (1), the animals were exposed to Context A(2) for a second time, where they underwent an additional session of fear conditioning. All animals were sacrificed 90 min after the beginning of the test session in Context A (2).
